Bourgeon Capital Management LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bourgeon Capital Management LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) during the 4th quarter, HoldingsChannel.com reports. The fund bought 1,356 shares of the medical equipment provider’s stock, valued at approximately $708,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Perfromance Wealth Partners LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at $204,000. Mitsubishi UFJ Asset Management UK Ltd. increased its holdings in Intuitive Surgical by 268.8% during the 4th quarter. Mitsubishi UFJ Asset Management UK Ltd. now owns 5,900 shares of the medical equipment provider’s stock valued at $3,080,000 after purchasing an additional 4,300 shares during the period. Mogy Joel R Investment Counsel Inc. raised its position in Intuitive Surgical by 1.2% during the 4th quarter. Mogy Joel R Investment Counsel Inc. now owns 66,906 shares of the medical equipment provider’s stock valued at $34,922,000 after purchasing an additional 800 shares during the last quarter. Atomi Financial Group Inc. lifted its holdings in Intuitive Surgical by 71.5% in the 4th quarter. Atomi Financial Group Inc. now owns 2,337 shares of the medical equipment provider’s stock worth $1,220,000 after buying an additional 974 shares during the period. Finally, Transform Wealth LLC grew its position in shares of Intuitive Surgical by 63.9% in the 4th quarter. Transform Wealth LLC now owns 8,205 shares of the medical equipment provider’s stock worth $4,283,000 after buying an additional 3,199 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 43,509 shares of company stock valued at $22,602,212. Insiders own 0.80% of the company’s stock.

Analyst Ratings Changes

Several analysts recently weighed in on ISRG shares. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Leerink Partners upped their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

View Our Latest Analysis on Intuitive Surgical

Intuitive Surgical Trading Up 1.9 %

NASDAQ:ISRG opened at $604.12 on Wednesday. The company has a market cap of $215.18 billion, a PE ratio of 97.13, a price-to-earnings-growth ratio of 5.04 and a beta of 1.39. The company has a 50 day simple moving average of $541.80 and a two-hundred day simple moving average of $500.76. Intuitive Surgical, Inc. has a 12 month low of $362.14 and a 12 month high of $606.27.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.